SLPI and diabetic kidney disease: Secretory leukocyte protease inhibitor (SLPI), a protein with broad anti-inflammatory and immunoregulatory functions, its expression had altered in diabetic nephropathy (DN), likely linked to its role in reducing inflammation and protecting the kidneys from damage (87).